PROS1 and infection: The S protein vaccines such as BNT162b2, ChAdOx1 nCoV-19 and Ad.26.COV.2.S (Janssen/Johnson & Johnson) showed reduced efficacy against Delta variant compared to the Alpha, but still provided protection; however, breakthrough infections were observed [77,78].